MARATTO

article · The Lancet Global Health

Intravenous ferric carboxymaltose versus oral ferrous sulphate for the treatment of moderate-to-severe postpartum anaemia in Nigerian women (IVON-PP): an open-label, randomised controlled trial

In plain language

The abstract on record is too brief for a reliable plain-language summary, so none has been generated.

Abstract

Bill & Melinda Gates Foundation.

Research topics

  • Maternal and fetal healthcare
  • Iron Metabolism and Disorders
  • Pregnancy and preeclampsia studies

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1016/s2214-109x(26)00001-x

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.